Published in Law and Health Weekly, March 19th, 2005
This patent will cover compositions and methods of use of the company's investigational agent, amonafide (Quinamed), to improve or "chemopotentiate" the anticancer effects of common chemotherapeutics, including cisplatin, paclitaxel, vinblastine, and camptothecin.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.